-
公开(公告)号:JPH1171323A
公开(公告)日:1999-03-16
申请号:JP13548798
申请日:1998-05-18
Applicant: HOECHST AG
Inventor: ARETZ WERNER , BOETTGER DIRK , SEIBERT GERHARD , TUMULKA ALOIS , WELZEL PETER , HOBERT KURT
IPC: A61K31/19 , A61P31/04 , C07C59/125 , C07C59/60 , C07F9/09 , C07F9/655 , C07H13/12 , C07H15/203 , C12N1/20 , C12N9/16 , C12N9/99 , C12P7/42 , C12P9/00 , C12P19/26 , C12P19/44 , C12R1/07
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound useful as an antibacterial agent or its intermediate. SOLUTION: The objective compound is a cleavage product of a phosphoglycolipid antibiotic substance of the formula I (R is H; R is a 5-55C alkyl). A cultured product of Bacillus DSM 4675 or its processed product, especially a separated enzyme is usable for the decomposition of a phosphoglycolipid antibiotic substance, especially antibiotic substances of moenomycin group. Moenomycin A is incubated with moenomycinase preferably at pH 8.2-8.3 and 49-51 deg.C to obtain the compounds of the formula II and III and the compound of the formula III is incubated with an MBase preferably at pH 6-8 and 35-37 deg.C for 24 hr to obtain the compound of the formula IV. The reaction product can be used as an antibiotic substance (e.g. the compound of the formula III) or a basic unit (e.g. the compound of the formula II and IV) in the synthesis of a transglycosylase inhibitor.
-
公开(公告)号:JPH09163998A
公开(公告)日:1997-06-24
申请号:JP31575096
申请日:1996-11-27
Applicant: HOECHST AG
Inventor: BADZIONG WERNER , HABERMANN PAUL , MOELLER JOERG , ARETZ WERNER
IPC: C12N15/09 , C07K14/575 , C07K14/62 , C07K14/815 , C07K19/00 , C12N15/81 , C12P21/00 , C12P21/02 , C12R1/645
-
公开(公告)号:AU711203B2
公开(公告)日:1999-10-07
申请号:AU7199696
申请日:1996-11-26
Applicant: HOECHST AG
Inventor: BADZIONG WERNER , HABERMANN PAUL , MOLLER JORG , ARETZ WERNER
IPC: C12N15/09 , C07K14/575 , C07K14/62 , C07K14/815 , C07K19/00 , C12N15/81 , C12P21/00 , C12P21/02 , C12R1/645
Abstract: Production of a recombinant protein (I) using a yeast strain that expresses a (I)-encoding heterologous gene under the control of an alcohol dehydrogenase (ADH) II promoter system comprises: (a) inoculating a production medium with a preculture of the yeast; (b) immediately initiating glucose supply at a constant rate of 0.7-1.4 g/l/hr; (c) maintaining the culture under aerobic conditions for about 2 days, and (d)isolating (I) from the culture broth.
-
公开(公告)号:CA1340504C
公开(公告)日:1999-04-20
申请号:CA556683
申请日:1988-01-15
Applicant: HOECHST AG
Inventor: ARETZ WERNER , SAUBER KLAUS
IPC: C12N1/20 , C12N9/10 , C12P35/00 , C12P35/02 , C12P35/06 , C12R1/06 , C12R1/125 , C12R1/37 , C12R1/38 , C12R1/385 , C12R1/40
Abstract: The invention relates to substantially purified .gamma.-glutamyltranspeptidase (.gamma.-GTP) having the following characteristics: - a molecular weight of 23,000 to 40,000 Dalton - a isoelectric point at a pH between 5.0 and 6.5, - a pH optimum of 6.5 to 10 with L-.gamma.-glutamylparanitroanilide as substrate - a K m of 9 to 36 .mu.M at pH 8, and - the ability to hydrolyze glutaryl- or adipinyl-monoamino compounds - obtainable by fermentation of bacteria of one or more of the genus Pseudomonas, Proteus, Arthrobacter and Bacillus.
-
公开(公告)号:CA2160861A1
公开(公告)日:1996-04-20
申请号:CA2160861
申请日:1995-10-18
Applicant: HOECHST AG
Inventor: ARETZ WERNER , HOLST ULRICH , KOLLER KLAUS PETER
IPC: C12N15/09 , C07H21/04 , C12N9/80 , C12N15/31 , C12N15/67 , C12N15/72 , C12R1/19 , C12N15/55 , C12N15/70
Abstract: The invention relates to a recombinant process for preparing glutarylamidase (GA), wherein the GA gene is expressed constitutively from an expression vector. In certain embodiments, the promoter for constitutively expressing the GA gene is atrc promoter or a trc-equivalent promoter which does not have any repressor or has a non-functional repressor.
-
公开(公告)号:CA2135041A1
公开(公告)日:1995-05-05
申请号:CA2135041
申请日:1994-11-03
Applicant: HOECHST AG
Inventor: ARETZ WERNER , HEDTMANN UDO
IPC: C07C59/60 , C07C59/90 , C07H3/06 , C07H11/04 , C07H13/12 , C12N1/16 , C12P7/42 , C12R1/645 , C12N1/20 , A61K31/70
Abstract: MA having a hydroxylated or oxidized lipid side chain and moenomycin analogs, a process for preparation and the use of these compounds The invention relates to MA of the formula I I in which R1,R2,R4 and R5 independently of one another are a hydroxyl group or hydrogen and R3 is hydrogen, the bond between the carbon atom carrying the substituent R4 and the carbon atom carrying the substituent R5 being a single bond, or R1 and R2 independently of one another are a hydroxyl group or hydrogen and R3 is hydrogen, the bond between the carbon atom carrying the substituent R4 and the carbon atom carrying the substituent R5 being a double bond, or R1,R2 and R5 independently of one another are a hydroxyl group or hydrogen and R3 and R4 together are an oxo group MA is hydroxylated or oxidized in the lipid side chain by microorganisms of the genus Cryptococcus and in this form is a starting compound for the preparation of moenomycin analogs which can be employed as pharmaceuticals. The moenomycin analogs have the following chemical structure: II in which R1 to R5 have the abovementioned meaning>
-
公开(公告)号:NO944197D0
公开(公告)日:1994-11-03
申请号:NO944197
申请日:1994-11-03
Applicant: HOECHST AG
Inventor: ARETZ WERNER , HEDTMANN UDO
IPC: C07C59/60 , C07C59/90 , C07H3/06 , C07H11/04 , C07H13/12 , C12N1/16 , C12P7/42 , C12R1/645 , C07C
Abstract: The invention relates to MA of the formula I in which R , R , R and R independently of one another are a hydroxyl group or hydrogen and R is hydrogen, where the bond between the C atom carrying the substituent R and the C atom carrying the substituent R is a single bond, or R and R independently of one another are a hydroxyll group or hydrogen and R is hydrogen, where the bond between the C atom carrying the substituent R and the C atom carrying the substituent R is a double bond, or R , R and R independently of one another are a hydroxyl group or hydrogen and R and R together are an oxo group. MA is hydroxylated or oxidised in the lateral lipid chain by microorganisms of the order Cryptococcus and in this form is a starting compound for the preparation of moenomycin analogues which can be employed as medicaments. The moenomycin analogues have the following chemical structure: in which R to R have the abovementioned meanings.h
-
公开(公告)号:NO171416C
公开(公告)日:1993-03-10
申请号:NO880171
申请日:1988-01-15
Applicant: HOECHST AG
Inventor: ARETZ WERNER , SAUBER KLAUS
IPC: C12N1/20 , C12N9/10 , C12P35/00 , C12P35/02 , C12P35/06 , C12R1/06 , C12R1/125 , C12R1/37 , C12R1/38 , C12R1/385 , C12R1/40 , C12P21/00 , C12Q1/48
Abstract: Using a gamma -glutamyltranspeptidase which can be prepared by fermentation, it is possible to hydrolyse adipinyl- or glutaryl-monoamino compounds, in particular alpha -keto-adipinyl- or glutaryl-7-aminocephalosporanic acid.
-
公开(公告)号:CA2062446A1
公开(公告)日:1992-09-09
申请号:CA2062446
申请日:1992-03-06
Applicant: HOECHST AG
Inventor: ARETZ WERNER , EHLERS EBERHARD , HEDTMANN UDO
Abstract: HOE 91/F 069 A process for the preparation of MA The invention relates to a process for the preparation of MA, which ensures MA production by enzymatic catalysis in glycine/NaOH buffer, and by the use of a phosphatecontaining culture medium for Bacillus sp. DSM 4675 and by extraction of the biomass with acetone.
-
公开(公告)号:HU202917B
公开(公告)日:1991-04-29
申请号:HU650788
申请日:1988-12-20
Applicant: HOECHST AG
Inventor: ARETZ WERNER , SAUBER KLAUS
Abstract: gamma -Glutamyltranspeptidase, which can be prepared by fermentation, can be used to hydrolyse alpha -aminoadipinyl-monoamino compounds, especially D-( delta )- alpha -aminoadipinyl-7-aminocephalosporanic acid.
-
-
-
-
-
-
-
-
-